195 related articles for article (PubMed ID: 7928698)
21. Nocardithiocin, a novel thiopeptide antibiotic, produced by pathogenic Nocardia pseudobrasiliensis IFM 0757.
Mukai A; Fukai T; Hoshino Y; Yazawa K; Harada K; Mikami Y
J Antibiot (Tokyo); 2009 Nov; 62(11):613-9. PubMed ID: 19745839
[TBL] [Abstract][Full Text] [Related]
22. Watasemycins A and B, new antibiotics produced by Streptomyces sp. TP-A0597.
Sasaki O; Igarashi Y; Saito N; Furumai T
J Antibiot (Tokyo); 2002 Mar; 55(3):249-55. PubMed ID: 12014439
[TBL] [Abstract][Full Text] [Related]
23. Ligand-induced changes in the Streptomyces lividans TipAL protein imply an alternative mechanism of transcriptional activation for MerR-like proteins.
Chiu ML; Viollier PH; Katoh T; Ramsden JJ; Thompson CJ
Biochemistry; 2001 Oct; 40(43):12950-8. PubMed ID: 11669632
[TBL] [Abstract][Full Text] [Related]
24. Novel triene-beta-lactone antibiotics, oxazolomycin derivative and its isomer, produced by Streptomyces sp. KSM-2690.
Otani T; Yoshida KI; Kubota H; Kawai S; Ito S; Hori H; Ishiyama T; Oki T
J Antibiot (Tokyo); 2000 Dec; 53(12):1397-400. PubMed ID: 11217805
[No Abstract] [Full Text] [Related]
25. YM-266183 and YM-266184, novel thiopeptide antibiotics produced by Bacillus cereus isolated from a marine sponge II. Structure elucidation.
Suzumura K; Yokoi T; Funatsu M; Nagai K; Tanaka K; Zhang H; Suzuki K
J Antibiot (Tokyo); 2003 Feb; 56(2):129-34. PubMed ID: 12715872
[TBL] [Abstract][Full Text] [Related]
26. Novel antibiotics, furaquinocins C, D, E, F, G and H.
Ishibashi M; Funayama S; Anraku Y; Komiyama K; Omura S
J Antibiot (Tokyo); 1991 Apr; 44(4):390-5. PubMed ID: 2032947
[TBL] [Abstract][Full Text] [Related]
27. Construction of pDYN6902, a new Streptomyces integrative expression vector designed for cloning sequences interfering with Escherichia coli viability.
Thibessard A; Bertrand C; Hiblot J; Piotrowski E; Leblond P
Plasmid; 2015 Nov; 82():43-9. PubMed ID: 26476355
[No Abstract] [Full Text] [Related]
28. Nisamycin, a new manumycin group antibiotic from Streptomyces sp. K106.
Hayashi K; Nakagawa M; Fujita T; Tanimori S; Nakayama M
J Antibiot (Tokyo); 1993 Dec; 46(12):1904-7. PubMed ID: 8294252
[No Abstract] [Full Text] [Related]
29. RS-22A, B and C: new macrolide antibiotics from Streptomyces violaceusniger. II. Physico-chemical properties and structure elucidation.
Ubukata M; Morita T; Osada H
J Antibiot (Tokyo); 1995 Apr; 48(4):293-9. PubMed ID: 7775265
[TBL] [Abstract][Full Text] [Related]
30. Tetronomycin, a novel polyether of unusual structure.
Keller-Juslén C; King HD; Kuhn M; Loosli HR; Pache W; Petcher TJ; Weber HP; von Wartburg A
J Antibiot (Tokyo); 1982 Feb; 35(2):142-50. PubMed ID: 7076564
[TBL] [Abstract][Full Text] [Related]
31. 16-Methyloxazolomycin, a new antimicrobial and cytotoxic substance produced by a Streptomyces sp.
Ryu G; Hwang S; Kim SK
J Antibiot (Tokyo); 1997 Dec; 50(12):1064-6. PubMed ID: 9510916
[No Abstract] [Full Text] [Related]
32. Thiostrepton-induced gene expression in Streptomyces lividans.
Murakami T; Holt TG; Thompson CJ
J Bacteriol; 1989 Mar; 171(3):1459-66. PubMed ID: 2537819
[TBL] [Abstract][Full Text] [Related]
33. Secondary metabolites by chemical screening. Part 19. SM 196 A and B, novel biologically active angucyclinones from Streptomyces sp.
Grabley S; Hammann P; Hütter K; Kluge H; Thiericke R; Wink J; Zeeck A
J Antibiot (Tokyo); 1991 Jun; 44(6):670-3. PubMed ID: 1649152
[No Abstract] [Full Text] [Related]
34. A novel isoquinoline alkaloid, DD-carboxypeptidase inhibitor, with antibacterial activity isolated from Streptomyces sp. 8812. Part II: Physicochemical properties and structure elucidation.
Solecka J; Sitkowski J; Bocian W; Bednarek E; Kawecki R; Kozerski L
J Antibiot (Tokyo); 2009 Oct; 62(10):581-5. PubMed ID: 19713991
[TBL] [Abstract][Full Text] [Related]
35. Napsamycins, new Pseudomonas active antibiotics of the mureidomycin family from Streptomyces sp. HIL Y-82,11372.
Chatterjee S; Nadkarni SR; Vijayakumar EK; Patel MV; Ganguli BN; Fehlhaber HW; Vertesy L
J Antibiot (Tokyo); 1994 May; 47(5):595-8. PubMed ID: 8040059
[No Abstract] [Full Text] [Related]
36. Secondary metabolites by chemical screening, 15. Structure and absolute configuration of naphthomevalin, a new dihydro-naphthoquinone antibiotic from Streptomyces sp.
Henkel T; Zeeck A
J Antibiot (Tokyo); 1991 Jun; 44(6):665-9. PubMed ID: 1906453
[No Abstract] [Full Text] [Related]
37. In vivo production of thiopeptide variants.
Zhang F; Kelly WL
Methods Enzymol; 2012; 516():3-24. PubMed ID: 23034221
[TBL] [Abstract][Full Text] [Related]
38. Essramycin: a first triazolopyrimidine antibiotic isolated from nature.
El-Gendy MM; Shaaban M; Shaaban KA; El-Bondkly AM; Laatsch H
J Antibiot (Tokyo); 2008 Mar; 61(3):149-57. PubMed ID: 18503193
[TBL] [Abstract][Full Text] [Related]
39. WS9761 A and B: new non-steroidal androgen-receptor antagonists produced by a Streptomyces.
Hori Y; Abe Y; Nakajima H; Shigematsu N; Takase S; Goto T; Okuhara M; Kohsaka M
J Antibiot (Tokyo); 1993 Dec; 46(12):1901-3. PubMed ID: 8294251
[No Abstract] [Full Text] [Related]
40. New cholesterol biosynthesis inhibitors MC-031 (O-demethylchlorothricin), -032 (O-demethylhydroxychlorothricin), -033 and -034.
Kawashima A; Nakamura Y; Ohta Y; Akama T; Yamagishi M; Hanada K
J Antibiot (Tokyo); 1992 Feb; 45(2):207-12. PubMed ID: 1556012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
